153 related articles for article (PubMed ID: 8331298)
1. Characterization of endothelin-binding sites in human skin and their regulation in primary Raynaud's phenomenon and systemic sclerosis.
Knock GA; Terenghi G; Bunker CB; Bull HA; Dowd PM; Polak JM
J Invest Dermatol; 1993 Jul; 101(1):73-8. PubMed ID: 8331298
[TBL] [Abstract][Full Text] [Related]
2. Localization of endothelin-1 and its binding sites in scleroderma skin.
Vancheeswaran R; Azam A; Black C; Dashwood MR
J Rheumatol; 1994 Jul; 21(7):1268-76. PubMed ID: 7525957
[TBL] [Abstract][Full Text] [Related]
3. Endothelin and collagen vascular disease: a review with special reference to Raynaud's phenomenon and systemic sclerosis.
Yamane K
Intern Med; 1994 Oct; 33(10):579-82. PubMed ID: 7827371
[TBL] [Abstract][Full Text] [Related]
4. Autoradiographic localization of endothelin-1 binding sites in porcine skin.
Zhao YD; Springall DR; Wharton J; Polak JM
J Invest Dermatol; 1991 Jan; 96(1):152-4. PubMed ID: 1846165
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon.
Bunker CB; Terenghi G; Springall DR; Polak JM; Dowd PM
Lancet; 1990 Dec 22-29; 336(8730):1530-3. PubMed ID: 1979366
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Raynaud's disease.
Cooke JP; Marshall JM
Vasc Med; 2005 Nov; 10(4):293-307. PubMed ID: 16444858
[TBL] [Abstract][Full Text] [Related]
7. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
O'Reilly D; Taylor L; el-Hadidy K; Jayson MI
Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594
[TBL] [Abstract][Full Text] [Related]
8. Raynaud's phenomenon and systemic sclerosis.
Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
[TBL] [Abstract][Full Text] [Related]
9. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
Serri J; Legré R; Veit V; Guardia C; Gay AM
Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
[TBL] [Abstract][Full Text] [Related]
10. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
[TBL] [Abstract][Full Text] [Related]
11. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon.
Zamora MR; O'Brien RF; Rutherford RB; Weil JV
Lancet; 1990 Nov; 336(8724):1144-7. PubMed ID: 1978025
[TBL] [Abstract][Full Text] [Related]
12. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
[TBL] [Abstract][Full Text] [Related]
13. Evidence for an abnormal peripherally mediated vascular response to temperature in Raynaud's phenomenon.
Walmsley D; Goodfield MJ
Br J Rheumatol; 1990 Jun; 29(3):181-4. PubMed ID: 2357499
[TBL] [Abstract][Full Text] [Related]
14. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
Rychlik-Golema W; Mastej K; Adamiec R
Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
[TBL] [Abstract][Full Text] [Related]
15. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
Stoyneva Z
Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Raynaud's phenomenon.
Herrick AL
Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 in human skin: immunolocalization, receptor binding, mRNA expression, and effects on cutaneous microvascular endothelial cells.
Bull HA; Bunker CB; Terenghi G; Springall DR; Zhao Y; Polak JM; Dowd PM
J Invest Dermatol; 1991 Oct; 97(4):618-23. PubMed ID: 1658154
[TBL] [Abstract][Full Text] [Related]
18. Ascorbic acid does not improve endothelium-dependent flow-mediated dilatation of the brachial artery in patients with Raynaud's phenomenon secondary to systemic sclerosis.
Mavrikakis ME; Lekakis JP; Papamichael CM; Stamatelopoulos KS; Kostopoulos ChC; Stamatelopoulos SF
Int J Vitam Nutr Res; 2003 Feb; 73(1):3-7. PubMed ID: 12690904
[TBL] [Abstract][Full Text] [Related]
19. Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon.
Denton CP; Bunce TD; Dorado MB; Roberts Z; Wilson H; Howell K; Bruckdorfer KR; Black CM
Rheumatology (Oxford); 1999 Apr; 38(4):309-15. PubMed ID: 10378706
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon.
Gabrielli A; Di Loreto C; Taborro R; Candela M; Sambo P; Nitti C; Danieli MG; DeLustro F; Dasch JR; Danieli G
Clin Immunol Immunopathol; 1993 Sep; 68(3):340-9. PubMed ID: 8370185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
